Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels (vol 8, pg 1160, 2022)

被引：0
|
作者：
Ricciuti, B.
Wang, X.
Alessi, J., V
机构：
来源：
JAMA ONCOLOGY | 2022年 / 8卷 / 11期
关键词：
D O I：
10.1001/jamaoncol.2022.5957
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1702 / 1702
页数：1
相关论文
共 50 条
  • [31] PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients
    Krawczyk, Pawel
    Grenda, Anna
    Wojas-Krawczyk, Kamila
    Nicos, Marcin
    Kucharczyk, Tomasz
    Jarosz, Bozena
    Reszka, Katarzyna
    Pankowski, Juliusz
    Krukowska, Kinga
    Bozyk, Aleksandra
    Szumilo, Justyna
    Sawicki, Marek
    Trojanowski, Tomasz
    Milanowski, Janusz
    [J]. CANCER GENETICS, 2019, 237 : 10 - 18
  • [32] Tumor Infiltrating Lymphocytes Are Associated with Epithelial Expression of PD-L1 Protein, PD-L1 mRNA and Better Outcome in Non-Small Cell Lung Cancer
    Schalper, K. A.
    Velcheti, V.
    Carvajal-Hausdorf, D. E.
    Anagnostou, V.
    Syrigos, K.
    Gettinger, S.
    Chen, L.
    Herbst, R.
    Rimm, D. L.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 493A - 494A
  • [33] Plasma cell-free RNA PD-L1 or Tissue PD-L1 Protein Expression and Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer
    Walker, Paul R.
    Jayananda, Sriraksha
    Pasli, Melisa
    Muzaffarl, Mahvish
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E17 - E17
  • [34] A Study on the Clinical Significance of Blood Exosomal PD-L1 in Non-Small Cell Lung Cancer Patients and its Correlation with PD-L1 in Tumor Tissues
    Cheng, Yonghong
    Chang, Feiyun
    Gong, Yanmei
    Lu, Ping
    [J]. HORMONE AND METABOLIC RESEARCH, 2023, 55 (11) : 788 - 793
  • [35] PD-L1 expression in different samples of non-small cell lung cancer
    Kovacevic, M.
    Kern, I.
    [J]. VIRCHOWS ARCHIV, 2017, 471 : S104 - S104
  • [36] PD-L1 expression is associated with advanced non-small cell lung cancer
    Chen, Zhiquan
    Mei, Jiandong
    Liu, Lunxu
    Wang, Guochen
    Li, Zuosheng
    Hou, Jingpu
    Zhang, Qiuyang
    You, Zongbing
    Zhang, Liu
    [J]. ONCOLOGY LETTERS, 2016, 12 (02) : 921 - 927
  • [37] PD-L1 Expression and Molecular Alterations in Non-Small Cell Lung Cancer
    Ebare, K.
    Song, W.
    Opitz, L.
    Rosca, O.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (03): : S52 - S53
  • [38] PD-L1 expression: An emerging biomarker in non-small cell lung cancer
    Adam, Julien
    Planchard, David
    Marabelle, Aurelien
    Soria, Jean-Charles
    Scoazec, Jean-Yves
    Lantuejoul, Sylvie
    [J]. ANNALES DE PATHOLOGIE, 2016, 36 (01) : 94 - 102
  • [39] Association between very high PD-l1 expression versus high PD-l1 expression in patients receiving pembrolizumab as firstline treatment for advanced non-small cell lung cancer
    Shah, Syed Mohsin Mahmood
    Marmarelis, Melina
    Mamtani, Ronac
    Hubbard, Rebecca
    Hennessy, Sean
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 96 - 97
  • [40] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
12345